Clinical usefulness of virtual ablation guided catheter ablation of atrial fibrillation: prospective randomized study II: Virtual rotor mapping and catheter ablation CUVIA-AF II”

Yonsei University Health System, Severance Hospital0 个研究点目标入组 660 人开始时间: 待定最近更新: 2023年1月10日

试验速览

暂无简介。

•legal age over 19 years old or capable of providing consent for the target according to national law
•- Patients undergoing atrial fibrillation electrode ceramic resection in accordance with treatment guidelines, or patients who need electrode ceramic resection again due to recurrence or recurrence after maze surgery
•- Patients who meet the HIRA's criteria for atrial fibrillation re-treatment
•- Patients who are free from adverse reactions, economic problems, and other anticoagulants

•- Patients who are scheduled to receive atrial fibrillation, but do not agree with this study and do not want to register
•- Older patients over 81 years of age
•- The patient who have renal disease of eGFR<30mL/min
•- Patients with other vascular diseases that require maintenance of antiplatelet drugs other than anticoagulants during treatment
•- Patients who have difficulty performing atrial fibrillation in a conventional manner due to structural abnormalities of the heart
•- Patients who have previously experienced major hemorrhagic complications from the use of anticoagulants
•- The patient who have risk of ischemic cerebral infarction (CHA2DS2-VASc Score >5)
•- The patient have experienced ischemic cerebral infarction more 2 times
•- Atrial fibrillation patients accompanying structural heart disease with severe heart disease or hemodynamic effects
•- The patients who missed out to recording of 3D CT, echo and electrocardiography.

发起方